Liaoning He Eye Hospital Group Co. LTD. (301103) - Net Assets
Based on the latest financial reports, Liaoning He Eye Hospital Group Co. LTD. (301103) has net assets worth CN¥1.90 Billion CNY (≈ $278.07 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.23 Billion ≈ $326.62 Million USD) and total liabilities (CN¥331.80 Million ≈ $48.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Liaoning He Eye Hospital Group Co. LTD. (301103) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.90 Billion |
| % of Total Assets | 85.14% |
| Annual Growth Rate | 16.87% |
| 5-Year Change | 95.14% |
| 10-Year Change | N/A |
| Growth Volatility | 43.01 |
Liaoning He Eye Hospital Group Co. LTD. - Net Assets Trend (2019–2024)
This chart illustrates how Liaoning He Eye Hospital Group Co. LTD.'s net assets have evolved over time, based on quarterly financial data. Also explore 301103 asset base for the complete picture of this company's asset base.
Annual Net Assets for Liaoning He Eye Hospital Group Co. LTD. (2019–2024)
The table below shows the annual net assets of Liaoning He Eye Hospital Group Co. LTD. from 2019 to 2024. For live valuation and market cap data, see how much is Liaoning He Eye Hospital Group Co. LTD. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.88 Billion ≈ $275.06 Million |
-9.29% |
| 2023-12-31 | CN¥2.07 Billion ≈ $303.25 Million |
-4.77% |
| 2022-12-31 | CN¥2.18 Billion ≈ $318.45 Million |
+107.33% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.60 Million |
+8.97% |
| 2020-12-31 | CN¥963.29 Million ≈ $140.96 Million |
+11.79% |
| 2019-12-31 | CN¥861.70 Million ≈ $126.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Liaoning He Eye Hospital Group Co. LTD.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 65.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥61.34 Million | 3.26% |
| Other Components | CN¥1.82 Billion | 96.74% |
| Total Equity | CN¥1.88 Billion | 100.00% |
Liaoning He Eye Hospital Group Co. LTD. Competitors by Market Cap
The table below lists competitors of Liaoning He Eye Hospital Group Co. LTD. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Datang Corporation Renewable Power Co. Limited
STU:DT7
|
$459.07 Million |
|
Promotora de Informaciones SA
MC:PRS
|
$459.15 Million |
|
Shanghai Fudan Forward S&T Co Ltd
SHG:600624
|
$459.27 Million |
|
Zhejiang XinNong Chemical Co Ltd Class A
SHE:002942
|
$459.33 Million |
|
Dalian Thermal Power Co Ltd
SHG:600719
|
$458.84 Million |
|
Zinzino AB Series B
ST:ZZ-B
|
$458.82 Million |
|
Daewon Cable Co. Ltd. Preference Shares
KO:006345
|
$458.78 Million |
|
Linc AB
ST:LINC
|
$458.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Liaoning He Eye Hospital Group Co. LTD.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,075,313,837 to 1,879,813,771, a change of -195,500,066 (-9.4%).
- Net loss of 27,398,160 reduced equity.
- Dividend payments of 93,965,231 reduced retained earnings.
- Other factors decreased equity by 74,136,676.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-27.40 Million | -1.46% |
| Dividends Paid | CN¥93.97 Million | -5.0% |
| Other Changes | CN¥-74.14 Million | -3.94% |
| Total Change | CN¥- | -9.42% |
Book Value vs Market Value Analysis
This analysis compares Liaoning He Eye Hospital Group Co. LTD.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.73x to 1.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥7.28 | CN¥19.85 | x |
| 2020-12-31 | CN¥8.14 | CN¥19.85 | x |
| 2021-12-31 | CN¥8.87 | CN¥19.85 | x |
| 2022-12-31 | CN¥13.76 | CN¥19.85 | x |
| 2023-12-31 | CN¥13.13 | CN¥19.85 | x |
| 2024-12-31 | CN¥11.90 | CN¥19.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Liaoning He Eye Hospital Group Co. LTD. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.50%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.18x
- Recent ROE (-1.46%) is below the historical average (5.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 9.35% | 10.81% | 0.75x | 1.15x | CN¥-5.57 Million |
| 2020 | 10.41% | 11.95% | 0.62x | 1.40x | CN¥3.91 Million |
| 2021 | 8.23% | 8.97% | 0.68x | 1.35x | CN¥-18.60 Million |
| 2022 | 1.50% | 3.41% | 0.37x | 1.20x | CN¥-184.84 Million |
| 2023 | 3.06% | 5.36% | 0.48x | 1.20x | CN¥-143.98 Million |
| 2024 | -1.46% | -2.50% | 0.49x | 1.18x | CN¥-215.38 Million |
Industry Comparison
This section compares Liaoning He Eye Hospital Group Co. LTD.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,974,322,674
- Average return on equity (ROE) among peers: 8.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Liaoning He Eye Hospital Group Co. LTD. (301103) | CN¥1.90 Billion | 9.35% | 0.17x | $459.02 Million |
| Xian International Medical Investment Co Ltd (000516) | $5.33 Billion | -15.42% | 1.50x | $1.51 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $316.99 Million | 7.94% | 0.29x | $3.11 Billion |
| Hengkang Medical Group Co Ltd (002219) | $311.99 Million | 14.27% | 0.15x | $1.15 Billion |
| Aier Eye Hospital Group (300015) | $2.06 Billion | 15.00% | 0.24x | $14.71 Billion |
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | $948.30 Million | 9.90% | 1.45x | $1.03 Billion |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $5.13 Billion | 10.02% | 0.31x | $2.24 Billion |
| Sanbo Hospital Management Group Ltd. A (301293) | $1.24 Billion | 6.18% | 0.44x | $1.93 Billion |
| Top Choice Medical Investment Co Inc (600763) | $454.39 Million | 20.04% | 0.12x | $2.76 Billion |
About Liaoning He Eye Hospital Group Co. LTD.
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia preven… Read more